James J. Vaughn, Chief Commercial Officer at GENOMIC HEALTH INC (GHDX), sold 4,444 shares at $58.94 ($259K) on 2019-05-08, disclosed to the SEC on 2019-05-10.
Open-market sale of $259k GHDX by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.82 | 1,044 | $60K | 23.3% |
| 2 | $57.89 | 1,258 | $73K | 28.1% |
| 3 | $58.91 | 1,142 | $67K | 25.9% |
| 4 | $58.94 | 1,000 | $59K | 22.7% |
| Total | $58.37 avg | 4,444 | $259K | 100% |
| Filing → |
| GHDX | SELL | 2019-09-11 | $311K | — | Filing → |
| GHDX | SELL | 2019-08-12 | $332K | — | Filing → |
| GHDX | SELL | 2019-08-12 | $273K | — | Filing → |